Search

Your search keyword '"José María Gámez"' showing total 12 results
Start Over Author "José María Gámez"
12 results on '"José María Gámez"'

2. Valvulopatía mitral y tricuspídea: diagnóstico y tratamiento. Posicionamiento conjunto de la Sección de Valvulopatías y las Asociaciones de Imagen, Cardiología Clínica y Cardiología Intervencionista de la SEC

Author

Ignacio Cruz-González, Rodrigo Estévez-Loureiro, Manuel Barreiro-Pérez, Almudena Aguilera-Saborido, Carmen Olmos-Blanco, Luis Miguel Rincón, Juan Carlos Gómez-Polo, Dabit Arzamendi, Luis Borreguero, Isidre Vilacosta, José María Gámez, and Amparo Martínez-Monzonis

Subjects
Cardiology and Cardiovascular Medicine
Published
2022
Full Text
View/download PDF

5. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

Author

David Calvo, Elena Arbelo, Fernando Arribas, Juan Cosín, José María Gámez, Javier Jiménez Candil, Miriam Juárez, Francisco Marín, Silvia Pérez Ortega, Pablo Jorge Pérez, Concepción Alonso, Albert Ariza, Felipe Atienza, Vivencio Barrios, Begoña Benito, Vicente Bertomeu, Carlos Escobar, Esteban López de Sá, Ana Martin, Roberto Martín Asenjo, Marta Pachón, Marta Pombo, Pablo Avanzas, Gemma Berga Congost, Araceli Boraita, Héctor Bueno, Raquel Campuzano, Victoria Delgado, Laura Dos, Ignacio Ferreira-González, Juan José Gómez Doblas, Domingo Pascual Figal, Antonia Sambola Ayala, Ana Viana Tejedor, José Luis Ferreiro, and Fernando Alfonso

Subjects
medicine.medical_specialty, business.industry, Internal medicine, medicine, Cardiology, Management of atrial fibrillation, General Medicine, business
Published
2021
Full Text
View/download PDF

6. Comentarios a la guía ESC/EACTS 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular

Author

David Calvo, Elena Arbelo, Fernando Arribas, Juan Cosín, José María Gámez, Javier Jiménez Candil, Miriam Juárez, Francisco Marín, Silvia Pérez Ortega, Pablo Jorge Pérez, Albert Ariza, Felipe Atienza, Vivencio Barrios, Begoña Benito, Vicente Bertomeu, Carlos Escobar, Esteban López de Sá, Ana Martin, Roberto Martín Asenjo, Marta Pachón, Marta Pombo, Pablo Avanzas, Gemma Berga Congost, Araceli Boraita, Héctor Bueno, Raquel Campuzano, Victoria Delgado, Laura Dos, Ignacio Ferreira-González, Juan José Gómez Doblas, Domingo Pascual Figal, Antonia Sambola, Ana Viana Tejedor, José Luis Ferreiro, and Fernando Alfonso

Subjects
Cardiology and Cardiovascular Medicine
Published
2021
Full Text
View/download PDF

8. Diagnosis and treatment of patients with ANOCA

Author

Carlos Escobar, Josep Gómez Lara, Javier Escaned, Antoni Carol Ruiz, Enrique Gutiérrez Ibañes, Leticia Fernández Friera, Sergio Raposeiras-Roubín, Joaquín Alonso Martín, Jaume Agüero, Jose María Gámez, Pablo Jorge-Pérez, Román Freixa-Pamias, Vivencio Barrios, Ignacio Cruz González, Amparo Martínez Monzonís, and Ana Viana Tejedor

Subjects
ANOCA, INOCA, Microvascular dysfunction, Vasospastic angina, Medicine
Abstract

ABSTRACT A substantial number of patients undergoing coronary angiography for angina or ischemia in noninvasive tests have coronary arteries without lesions or with nonsignificant stenosis. Many of these patients have nonobstructive myocardial ischemia (INOCA/ANOCA), which is an entity with prognostic importance that significantly affects patients’ quality of life. The absence of a proper diagnosis leads to inappropriate medical treatment, repeat diagnostic tests, and greater use of social and health resources. An adequate diagnostic strategy is required for individualized treatment that improves symptoms and quality of life. In this document from the SEC-Clinical Cardiology Association, SEC Interventional Cardiology Association, SEC-Ischemic Heart Disease and Acute Cardiac Care Association, and SEC-Cardiovascular Imaging Association of the Spanish Society of Cardiology, we provide simple and practical algorithms, with the aim of facilitating the early diagnosis and most appropriate treatment for patients with ANOCA. Keywords: ANOCA. INOCA. Microvascular dysfunction. Vasospastic angina. RESUMEN Un número importante de aquellos pacientes en quienes se realiza coronariografía por angina o isquemia presentan en pruebas no invasivas arterias coronarias sin lesiones o con estenosis no significativas. Muchos de estos pacientes tienen isquemia miocárdica de causa no obstructiva (INOCA/ANOCA), una condición con importancia pronóstica que afecta de manera considerable la calidad de vida. La ausencia de un diagnóstico que haga...

Published
2024
Full Text
View/download PDF

9. Diagnóstico y tratamiento de los pacientes con ANOCA.

Author

Carlos Escobar, Josep Gómez Lara, Javier Escaned, Antoni Carol Ruiz, Enrique Gutiérrez Ibañes, Leticia Fernández Friera, Sergio Raposeiras-Roubín, Joaquín Alonso Martín, Jaume Agüero, Jose María Gámez, Pablo Jorge-Pérez, Román Freixa-Pamias, Vivencio Barrios, Ignacio Cruz González, Amparo Martínez Monzonís, and Ana Viana Tejedor

Subjects
ANOCA, INOCA, Disfunción microvascular, Angina vasoespástica, Internal medicine, RC31-1245
Abstract

RESUMEN Un número importante de aquellos pacientes en quienes se realiza coronariografía por angina o isquemia presentan en pruebas no invasivas arterias coronarias sin lesiones o con estenosis no significativas. Muchos de estos pacientes tienen isquemia miocárdica de causa no obstructiva (INOCA/ANOCA), una condición con importancia pronóstica que afecta de manera considerable la calidad de vida. La ausencia de un diagnóstico que haga posible un tratamiento médico efectivo acarrea la repetición de pruebas diagnósticas y un mayor uso de recursos sociosanitarios. Es necesaria una estrategia diagnóstica adecuada para poder realizar un tratamiento personalizado, que mejore los síntomas y la calidad de vida. En este documento de la SEC-Asociación de Cardiología Clínica, SEC-Asociación de Cardiología Intervencionista, SEC-Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares, y SEC-Asociación de Imagen Cardiaca, se establecen unos algoritmos sencillos y prácticos con el objetivo de facilitar el diagnóstico precoz y el tratamiento más adecuado de los pacientes con ANOCA. Palabras clave: ANOCA. INOCA. Disfunción microvascular. Angina vasoespástica. ABSTRACT A substantial number of patients undergoing coronary angiography for angina or ischemia in noninvasive tests have coronary arteries without lesions or with nonsignificant stenosis. Many of these patients have nonobstructive myocardial ischemia (INOCA/ANOCA), which is an entity with prognostic importance that significantly affects patients’ quality of...

Published
2024
Full Text
View/download PDF

10. [Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology]

Author

David, Vivas, Vanessa, Roldán, María Asunción, Esteve-Pastor, Inmaculada, Roldán, Antonio, Tello-Montoliu, Juan Miguel, Ruiz-Nodar, Juan, Cosín-Sales, José María, Gámez, Luciano, Consuegra, José Luis, Ferreiro, and Francisco, Marín

Abstract

The new coronavirus SARS-CoV-2, which gives rise to the highly contagious COVID-19 disease, has caused a pandemic that is overwhelming health care systems worldwide. Affected patients have been reported to have a heightened inflammatory state that increases their thrombotic risk. However, there is very scarce information on the management of thrombotic risk, coagulation disorders, and anticoagulant therapy. In addition, the situation has also greatly influenced usual care in patients not infected with COVID-19. This article by the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology aims to summarize the available information and to provide a practical approach to the management of antithrombotic therapy.

Published
2020

11. Colaboradores

Author

Muñoz, Irene Albertos, Herrero, Irene Alcoceba, Trigo, Emma Argelich, Ávila, Javier Ávila, Velasco, Cristina Bouzas, Revenga, Javier Butragueño, Ballesteros, Leticia Cantero, Jiménez, Rafael Ángel Castro, Pipó, Javier Conde, Tejedor, Mar Cuadrado, Marcos, Domiciana de la Fuente, Arroyo, Carmen del Campo, Herrera, Raúl Domínguez, Zorzo, María Natividad Elvira, Cañabate, Sonia Fernández, Sánchez, M.ª del Rosario Ferreira, Martínez, José María Gámez, Barroso, Carolina García, Hernández, Silvia García, Marcos, José Manuel García, Solaesa, Ángela García, Blasi, Nuria Giménez, Cervantes, Sergio González, González, Leticia Heras, Sánchez, Sonsoles Hernández, Flores, María José Jiménez-Casquet, Rodríguez, José Antonio Latorre, García, Eva Pilar López, Mesa, Mario Manuel López, Moro, Alejandro López, Arcas, Miguel Mariscal, Almena, Francisco Javier Martín, Jiménez, Ana Martín, Bebia, Manuel Martínez, Álvarez, David Mateos, Ventola, Alejandra Rebeca Melero, Casillas, Luis Moreno, García, María Victoria Moreno, Lisa, Rosa Morillo, Santana, Marcos José Navarro, Martín, Rosario Pastor, Pérez, Lilisbeth Perestelo, Pacho, M.ª Teresa Prieto, Camacho, Patricia Montserrat Rodríguez, Sanz, David Rodríguez, González, José Sebastián Roldán, Jiménez, Elena Sánchez, Milá, Zacarías Sánchez, Ibáñez, Elena Rocío Serrano, Hernández, Víctor Tejedor, Marí, Josep Antoni Tur, Santiago, Sergio Vázquez, Saornil, Jorge Velázquez, Sánchez, Marina Wöbbeking, and Cano, Elena Zazo

Published
2024
Full Text
View/download PDF

12. The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans

Author

Tomás Ripoll Vera, Jordi Rosell Andreo, Joan Torres Marqués, Isabel Rodríguez García, Carlos Gómez Navarro, Lorenzo Monserrat Iglesias, Nancy Govea Callizo, Manuel Hermida Prieto, José María Gámez Martínez, David Cremer Luengos, Guillermo Pons Lladó, and Martín Ortiz

Subjects
medicine.medical_specialty, TNNT2, business.industry, Cardiomyopathy, Hypertrophic cardiomyopathy, TPM1, medicine.disease, Left ventricular hypertrophy, Sudden death, TNNI3, Internal medicine, cardiovascular system, medicine, Cardiology, MYH7, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business
Abstract

Background The R820W mutation in the MYBPC3 gene has been associated with the development of hypertrophic cardiomyopathy (HCM) in rag-doll cats, but had not been described in humans. Aims To describe the phenotype associated with the R820W mutation identified in a human family. Methods The R820W was identified by direct sequencing of the MYBPC3 gene in a 47year old woman with HCM and left ventricular non-compaction (LVNC). Clinical and genetic studies of the R820W mutation were performed in her family. Results The index patient was homozygous for the mutation and had no additional mutations in the main sarcomeric genes (MYH7, TNNT2, TNNI3, and TPM1). She had HCM with LVNC and normal systolic function. One brother had died suddenly at age 43years. Another brother diagnosed of LVNC with severe systolic dysfunction and a cardiac arrest was also homozgous for the mutation. One heterozygous 31year old sister, and three heterozygous sons of the index (ages 14, 20 and 23years old) were clinically unaffected. The father of the index was apparently healthy and her mother had atrial fibrillation and an electrocardiographic diagnosis of left ventricular hypertrophy at age 86years. Conclusion The R820W mutation in the MYBPC3 gene, previously associated with HCM in rag-doll cats, causes both HCM and LVNC in homozygous human carriers, with mild or null clinical expression in heterozygous carriers.

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results